Steven S. Pullen
Boehringer Ingelheim (Brazil)(BR)Boehringer Ingelheim (France)(FR)Boehringer Ingelheim (United States)(US)
Publications by Year
Research Areas
NF-κB Signaling Pathways, Liver Disease Diagnosis and Treatment, Immune Response and Inflammation, Birth, Development, and Health, Renal Diseases and Glomerulopathies
Most-Cited Works
- → Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice(2017)345 cited
- → CD40−Tumor Necrosis Factor Receptor-Associated Factor (TRAF) Interactions: Regulation of CD40 Signaling through Multiple TRAF Binding Sites and TRAF Hetero-Oligomerization(1998)246 cited
- → Renal compartment–specific genetic variation analyses identify new pathways in chronic kidney disease(2018)233 cited
- → Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients(2016)226 cited
- → Crystallographic analysis of CD40 recognition and signaling by human TRAF2(1999)196 cited
- → CD40 Signaling through Tumor Necrosis Factor Receptor-associated Factors (TRAFs)(1999)185 cited